CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 48 filers reported holding CANDEL THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.68 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $66,092 | – | 10,660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 1,935,215 | $11,998,333 | 21.71% |
| Sands Capital Ventures, LLC | 405,837 | $2,516,189 | 0.84% |
| Alpine Global Management, LLC | 18,761 | $116,318 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80,595 | $499,689 | 0.01% |
| Virtu Financial LLC | 22,639 | $140 | 0.01% |
| MML INVESTORS SERVICES, LLC | 73,376 | $455 | 0.00% |
| Point72 (DIFC) Ltd | 4,927 | $30,547 | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 813 | $5,041 | 0.00% |
| Schonfeld Strategic Advisors LLC | 21,452 | $133,002 | 0.00% |
| Nuveen Asset Management, LLC | 382,188 | $2,369,566 | 0.00% |